REFERENCES
- Lucas GM, Chaisson RE, Moore RD. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions. Ann Intern Med. 1999;131:81–87.
- Williams A, Friedland G. Adherence, compliance and HAART. AIDS Clin Care. 1997;9:51–55.
- Knobel H, Carmona A, Grau S, Pedro-Botet J, Diez A. Adherence and effectiveness of highly active antiretroviral therapy. Arch Intern Med. 1998;158:1993.
- Vanhove GF, Schapiro JM, Winters MA, Merigan TC, Blaschke TF. Patient compliance and drug failure in pro-tease inhibitor monotherapy. JAMA. 1996;276(24)1 955–1956.
- Recomendaciones del Consejo Asesor Clinico del Plan Nacional sobre el Sida. Trata-miento antirretroviral (4e edición). Madrid: Ministerio de Sanidad y Consumo; 1997.
- Besch CL. Compliance in clinical trials. AIDS. 1995;9:1–10.
- Sackett DL, Snow JS. The magnitude of compliance and non-compliance. In: Haynes RB, Taylor DW, Sackett DL, eds. Compliance in Health Care. Baltimore, MD: John Hopkins University Press; 1979:11–12.
- Rodriguez Rosado R, Jimenez Nacher I, Soriano V, Anton P, Gonzalez Lahoz J. Virological failure and adherence to antiretroviral therapy in HIV-infected patients. AIDS. 1998;12(9):1112–1113.
- Lopez Suarez A, Fernandez Gutierrez del Alamo, Perez Guzman E, Giron Gonzalez JA. Adherence to the antiretroviral treatment in asymptomatic HIV-infected pa-tients. AIDS. 1998;12(6):685–686
- Cohen OJ, Fauci A. Transmission of multidrug-resistant human immunodeficiency virus. The wake-up call. N Engl J Med. 1998;339:341–343.
- Wenger N, Gifford A, Liu H, et al. Patient adherence and attitudes associated with antiretroviral (AR) adherence. Sixth Conference on Retroviruses and Opportunistic Infec-tions; 1999; Chicago. Abstract 98.
- Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279:1977–1983.
- Richardson JL, Skilton DR, Krailo M, Levine AM. The effect of compliance with treatment on survival among patients with haematologic malignancies. J Clin Oncol. 1990;8:356–364.
- Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA. 1993;269:2779–2781.
- Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with monitoring of adherence to antihypertensive therapy. Med Care. 1999;37:846–857.
- Knobel H, Codina C, Mir6 JM, et al. Recomendaciones GESIDA/SEFH/PNS para mejorar la adherencia al tratamiento antirretroviral. Enferm lnfecc Microbiol Clin. 2000;18:27–39.
- Hecht FM. Measuring HIV treatment adherence in clinical practice. AIDS Clin Care. 1998;10:57–59.
- Hulley SB, Cummings SR. Clinical Research. An Epidemio-logic Approach. Spain, Madrid: Harcourt Brace; 1993.
- Sacket DL, Haynes RB, Tugwell P, eds. Cumplimiento. In: Epidemiologfa clfnica, una ciencia basica para la medicina clfnica. Madrid: Diaz de Santos; 1989:250–290.
- Gil V, Pineda M, Martinez JL, Beide J, Santos ML, Merino J. Validez de 6 métodos indirectos para valorar el cumplimiento terapeütico en la hipertensión arterial. Med Clin (Barc). 1994;102:532–536.
- Informe: Vigilancia epidemiológica del SIDA/ VIH en la Comunidad de Madrid. Boletin Epidemiológico de la Comunidad de Madrid. Consejeria de Sanidad y Servicios Sociales. Comunidad de Madrid. Vol 5, Julio-Agosto 1998.
- Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults: Updated recommendations of the Inter-national AIDS Society-USA Panel. JAMA. 2000;283:381–390.
- Farmer KC. Methods for measuring and monitoring medi-cation regimen adherence in clinical trials and clinical prac-tice. Clin Ther. 1999;21:1074–1090.
- Geletko SM, Segarra M, Mayer KH, et al. Electronic com-pliance assessment of antifungical prophylaxis for human immunodeficiency virus-infected women. Antimicrob Agents Chemother. 1996;40:1338–1341.
- Sherer R. Adherence and antiretroviral therapy in injection drug users. JAMA. 1998;280:567–568.
- Paterson D, Swindells S, Mohr J, et al. Adherence to pro-tease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133:21–30.
- Knobel H, Carmona A, Lopez JL, et al. Adherencia al tratamiento antirretroviral de alta actividad: Impacto del consejo individualizado. Enferm lnfecc Microbiol Clin. 1999;17:78–81.